Sentinel CH SPA recalls MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination…
- Recall date
- May 22, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2867-2017
- FDA classification
- Class II
- Brand / firm
- Sentinel CH SPA
- Sold / distributed
- Nationwide Distribution
Why it was recalled
Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2
Get recall alerts
Free email alert whenever Sentinel CH SPA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentinel CH SPA